Published in Int J Cancer on September 15, 2007
Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival. PLoS One (2011) 3.59
A new trick of an old molecule: androgen receptor splice variants taking the stage?! Int J Biol Sci (2011) 1.27
Yin Yang 1 regulates the transcriptional activity of androgen receptor. Oncogene (2009) 1.15
Profiling human androgen receptor mutations reveals treatment effects in a mouse model of prostate cancer. Mol Cancer Res (2008) 0.94
Constitutively active androgen receptor variants upregulate expression of mesenchymal markers in prostate cancer cells. PLoS One (2013) 0.91
Effects of sorafenib on C-terminally truncated androgen receptor variants in human prostate cancer cells. Int J Mol Sci (2012) 0.88
Cistrome plasticity and mechanisms of cistrome reprogramming. Cell Cycle (2012) 0.80
On the origins of the androgen receptor low molecular weight species. Horm Cancer (2013) 0.78
The epidemiology of renal cell carcinoma. Eur Urol (2011) 3.85
Factors associated with overall and attributable mortality in invasive aspergillosis. Clin Infect Dis (2008) 3.18
Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881. Eur Urol (2008) 2.55
Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery. Eur Urol (2009) 2.41
Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma. Eur Urol (2008) 2.37
Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol (2002) 2.31
Collecting duct renal cell carcinoma: a matched analysis of 41 cases. Eur Urol (2007) 2.30
Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population. Eur Urol (2011) 1.87
The expanding role of partial nephrectomy: a critical analysis of indications, results, and complications. Eur Urol (2009) 1.70
Prognostic value of microscopic venous invasion in renal cell carcinoma: long-term follow-up. Eur Urol (2004) 1.64
Prognostic value of microvascular invasion in predicting the cancer specific survival and risk of metastatic disease in renal cell carcinoma: a multicenter investigation. J Urol (2011) 1.63
Contrast enhanced color Doppler endorectal sonography of prostate: efficiency for detecting peripheral zone tumors and role for biopsy procedure. J Urol (2003) 1.62
The phosphoinositide 3-kinase/Akt pathway: a new target in human renal cell carcinoma therapy. Cancer Res (2006) 1.56
Constitutive activation of the androgen receptor by a point mutation in the hinge region: a new mechanism for androgen-independent growth in prostate cancer. Int J Cancer (2004) 1.54
[Kidney tumors]. Prog Urol (2007) 1.43
Identification of novel truncated androgen receptor (AR) mutants including unreported pre-mRNA splicing variants in the 22Rv1 hormone-refractory prostate cancer (PCa) cell line. Hum Mutat (2010) 1.37
Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies. Eur Urol (2009) 1.32
Relationship between age at diagnosis and clinicopathologic features of renal cell carcinoma. Eur Urol (2006) 1.27
Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendations. Eur Urol (2010) 1.24
A splicing variant of the androgen receptor detected in a metastatic prostate cancer exhibits exclusively cytoplasmic actions. Endocrinology (2007) 1.21
Geriatric oncology, general practitioners and specialists: current opinions and unmet needs. Crit Rev Oncol Hematol (2009) 1.18
STARD3 or STARD3NL and VAP form a novel molecular tether between late endosomes and the ER. J Cell Sci (2013) 1.16
The exon-junction-complex-component metastatic lymph node 51 functions in stress-granule assembly. J Cell Sci (2007) 1.16
The sonic hedgehog signaling pathway is reactivated in human renal cell carcinoma and plays orchestral role in tumor growth. Mol Cancer (2009) 1.15
Signal transduction pathways of taxanes-induced apoptosis. Curr Med Chem Anticancer Agents (2003) 1.14
Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: a predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas. Eur J Cancer (2012) 1.11
Pleiotropic functional properties of androgen receptor mutants in prostate cancer. Hum Mutat (2009) 1.11
Role of cationic channel TRPV2 in promoting prostate cancer migration and progression to androgen resistance. Cancer Res (2010) 1.09
Identification of a small TAF complex and its role in the assembly of TAF-containing complexes. PLoS One (2007) 1.08
MiniCD4 microbicide prevents HIV infection of human mucosal explants and vaginal transmission of SHIV(162P3) in cynomolgus macaques. PLoS Pathog (2012) 1.07
Severe intoxication with methotrexate possibly associated with concomitant use of proton pump inhibitors. Anticancer Res (2010) 1.05
Conditional survival predictions after nephrectomy for renal cell carcinoma. J Urol (2009) 1.02
From dynamic live cell imaging to 3D ultrastructure: novel integrated methods for high pressure freezing and correlative light-electron microscopy. PLoS One (2010) 1.02
Hormone escape is associated with genomic instability in a human prostate cancer model. Int J Cancer (2009) 1.00
Structural basis for highly effective HIV-1 neutralization by CD4-mimetic miniproteins revealed by 1.5 Å cocrystal structure of gp120 and M48U1. Structure (2013) 1.00
A mu-delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networks. Brain Struct Funct (2014) 1.00
Stabilization of HIV-1 envelope in the CD4-bound conformation through specific cross-linking of a CD4 mimetic. J Biol Chem (2011) 0.97
Perispeckles are major assembly sites for the exon junction core complex. Mol Biol Cell (2012) 0.95
Interfacial cavity filling to optimize CD4-mimetic miniprotein interactions with HIV-1 surface glycoprotein. J Med Chem (2013) 0.95
Comparative sensitivities of functional MRI sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or external-beam radiotherapy. AJR Am J Roentgenol (2013) 0.94
Role of the RNA-binding protein HuR in human renal cell carcinoma. Carcinogenesis (2010) 0.94
Suppressor of cytokine signaling (SOCS)-1 is expressed in human prostate cancer and exerts growth-inhibitory function through down-regulation of cyclins and cyclin-dependent kinases. Am J Pathol (2009) 0.94
von Hippel-Lindau tumor suppressor gene-dependent mRNA stabilization of the survival factor parathyroid hormone-related protein in human renal cell carcinoma by the RNA-binding protein HuR. Carcinogenesis (2008) 0.94
Straightforward selection of broadly neutralizing single-domain antibodies targeting the conserved CD4 and coreceptor binding sites of HIV-1 gp120. J Virol (2012) 0.93
Parathyroid hormone-related protein induces cell survival in human renal cell carcinoma through the PI3K Akt pathway: evidence for a critical role for integrin-linked kinase and nuclear factor kappa B. Carcinogenesis (2007) 0.93
Specific properties of a C-terminal truncated androgen receptor detected in hormone refractory prostate cancer. Adv Exp Med Biol (2008) 0.93
Diffuse primary angiosarcoma of the pleura: a case report and review of the literature. Sarcoma (2004) 0.92
Constitutively active androgen receptor variants upregulate expression of mesenchymal markers in prostate cancer cells. PLoS One (2013) 0.91
Targeting the nuclear factor-kappaB rescue pathway has promising future in human renal cell carcinoma therapy. Cancer Res (2007) 0.91
Parathyroid hormone-related protein is an essential growth factor for human clear cell renal carcinoma and a target for the von Hippel-Lindau tumor suppressor gene. Cancer Res (2004) 0.89
Live-cell one- and two-photon uncaging of a far-red emitting acridinone fluorophore. J Am Chem Soc (2010) 0.89
MR Imaging of papillary renal neoplasms: potential application for characterization of small renal masses. Eur Radiol (2006) 0.88
Adriamycin, cisplatin, ifosfamide and paclitaxel combination as front-line chemotherapy for locally advanced and metastatic angiosarcoma. Analysis of three case reports and review of the literature. Anticancer Res (2008) 0.88
Percutaneous MR-guided cryoablation of prostate cancer: initial experience. Eur Radiol (2012) 0.88
Significance of the pseudocapsule on MRI of renal neoplasms and its potential application for local staging: a retrospective study. AJR Am J Roentgenol (2005) 0.87
SOCS-3 antagonises the proliferative and migratory effects of fibroblast growth factor-2 in prostate cancer by inhibition of p44/p42 MAPK signalling. Endocr Relat Cancer (2010) 0.87
A V530I Mutation in c-KIT Exon 10 Is Associated to Imatinib Response in Extraabdominal Aggressive Fibromatosis. Sarcoma (2010) 0.87
MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency. Retrovirology (2012) 0.86
Off-label use of oxaliplatin in patients with metastatic breast cancer. Anticancer Res (2011) 0.86
In vivo visualization of delta opioid receptors upon physiological activation uncovers a distinct internalization profile. J Neurosci (2012) 0.86
[Internal hernia of the small intestine after laparoscopic nephrectomy]. Prog Urol (2006) 0.86
Gastrointestinal stromal tumor in an XYY/XY male. Cancer Genet Cytogenet (2002) 0.85
Tubeless percutaneous nephrolithotomy: what about replacing the Double-J stent with a ureteral catheter? J Endourol (2008) 0.85
A yeast-based functional assay for the detection of the mutant androgen receptor in prostate cancer. Eur J Endocrinol (2003) 0.85
Percutaneous renal cryoablation: prospective experience treating 120 consecutive tumors. AJR Am J Roentgenol (2013) 0.85
Partial versus radical nephrectomy in patients with adverse clinical or pathologic characteristics. Urology (2009) 0.84
Elicitation of neutralizing antibodies directed against CD4-induced epitope(s) using a CD4 mimetic cross-linked to a HIV-1 envelope glycoprotein. PLoS One (2012) 0.84
Successful treatment of a granulocytic sarcoma of the uterine cervix in complete remission at six-year follow-up. J Oncol (2010) 0.84
Antitumor effect of parathyroid hormone-related protein neutralizing antibody in human renal cell carcinoma in vitro and in vivo. Carcinogenesis (2005) 0.84
Retinoic acid deficiency impairs the vestibular function. J Neurosci (2013) 0.83